TY - JOUR
KW - Continuity of Patient Care
KW - Hepatitis C/drug therapy
KW - Humans
KW - Philadelphia
KW - Referral and Consultation
KW - Treatment Outcome
KW - behavioral health
KW - Drug policy
KW - Hepatitis C
KW - mental illness
KW - primary care
KW - substance use
AU - K. Grosgebauer
AU - T. S. Bartholomew
AU - K. Huynh
AU - T. Cos
A1 - 
AB - Hepatitis C virus (HCV) infection is a public health issue that claims the lives of 350,000 individuals globally every year. Primary care providers are increasingly prescribing HCV medications with more modern, simplified administrations. Individuals with HCV are disproportionately affected by behavioral health challenges and substance use disorders. Integrated behavioral health providers can work in concert with their patients' primary care teams to provide innovative treatment programs to help support the needs of HCV care. We used simple and multivariable logistic regression to determine the association between receipt of behavioral health consultation and two outcomes on the care continuum: insurance approval for treatment and initiated HCV treatment regimen. These models were fitted using theoretically hypothesized variables and multivariable regression models included age, sex, and race/ethnicity as potential confounders. From January 2015 to May 2017, 189 patients at health centers were referred for onsite HCV primary care treatment. Of these, 142 were approved for participation, and 132 started treatment. Simple regression revealed a significant association between behavioral health consultation and treatment approval; however, behavioral health consultation was non-significant in the multivariable model for treatment approval. For initiating HCV treatment, onsite behavioral health consultation was significantly associated in both the unadjusted and adjusted regression models. Integrating behavioral health services for patients seeking HCV treatment may improve movement across the care continuum, optimizing patient's HCV health outcomes. Behavioral health consultation in primary care settings should be studied further to improve HCV treatment outcomes for patients with behavioral health and substance use disorders.
AD - Department of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14th St, Miami, FL, 33136, USA.; National Nurse-Led Care Consortium, Philadelphia, PA, USA. tsb61@miami.edu.; Department of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14th St, Miami, FL, 33136, USA. tsb61@miami.edu.; Public Health Management Corporation, Philadelphia, PA, USA.; Public Health Management Corporation, Philadelphia, PA, USA.; Department of Psychology, La Salle University, Philadelphia, PA, USA.
BT - The journal of primary prevention
C5 - Healthcare Disparities; Opioids & Substance Use
CP - 2
DO - 10.1007/s10935-021-00627-2
IS - 2
JF - The journal of primary prevention
LA - eng
M1 - Journal Article
N2 - Hepatitis C virus (HCV) infection is a public health issue that claims the lives of 350,000 individuals globally every year. Primary care providers are increasingly prescribing HCV medications with more modern, simplified administrations. Individuals with HCV are disproportionately affected by behavioral health challenges and substance use disorders. Integrated behavioral health providers can work in concert with their patients' primary care teams to provide innovative treatment programs to help support the needs of HCV care. We used simple and multivariable logistic regression to determine the association between receipt of behavioral health consultation and two outcomes on the care continuum: insurance approval for treatment and initiated HCV treatment regimen. These models were fitted using theoretically hypothesized variables and multivariable regression models included age, sex, and race/ethnicity as potential confounders. From January 2015 to May 2017, 189 patients at health centers were referred for onsite HCV primary care treatment. Of these, 142 were approved for participation, and 132 started treatment. Simple regression revealed a significant association between behavioral health consultation and treatment approval; however, behavioral health consultation was non-significant in the multivariable model for treatment approval. For initiating HCV treatment, onsite behavioral health consultation was significantly associated in both the unadjusted and adjusted regression models. Integrating behavioral health services for patients seeking HCV treatment may improve movement across the care continuum, optimizing patient's HCV health outcomes. Behavioral health consultation in primary care settings should be studied further to improve HCV treatment outcomes for patients with behavioral health and substance use disorders.
PY - 2021
SN - 1573-6547; 0278-095X
SP - 203
EP - 215
EP - 
T1 - Impact of Behavioral Health Consultation on Hepatitis C Treatment Outcomes at a Federally Qualified Health Center; Philadelphia, PA
T2 - The journal of primary prevention
TI - Impact of Behavioral Health Consultation on Hepatitis C Treatment Outcomes at a Federally Qualified Health Center; Philadelphia, PA
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 33733379
U3 - 10.1007/s10935-021-00627-2
VL - 42
VO - 1573-6547; 0278-095X
Y1 - 2021
Y2 - Apr
ER -